Sun Pharmaceutical Industries Ltd.
Snapshot View

930.65 +12.80 ▲1.4%

29 September 2022, 01:34:59 PM
Volume: 6,763,022

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.sunpharma.com
Market Cap 226,737.15 Cr.
Enterprise Value(EV) 216,120.30 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 16.21 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 58.30 Trailing Twelve Months Ending 2022-06
Industry PE 30.82 Trailing Twelve Months Ending 2022-06
Book Value / Share 208.84 Trailing Twelve Months Ending 2022-06
Price to Book Value 4.53 Calculated using Price: 945.00
Dividend Yield 1.06 Period Ending 2022-03
No. of Shares Subscribed 239.93 Cr. 2,399,334,970 Shares
FaceValue 1
Company Profile
The company is among the largest specialty generic pharmaceutical company and India's top pharmaceutical company. A vertically integrated business and a skilled team enables it to deliver high-quality products, trusted by customers and patients in many countries across the world, at affordable prices.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+1.39%
1 Week
+2.49%
1 Month
+5.85%
3 Month
+10.96%
6 Month
+1.23%
1 Year
+14.71%
2 Year
+83.87%
5 Year
+84.93%
10 Year
+167.60%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 23.15 24.89 19.32 22.51 6.85 8.05 9.66 4.98 7.21
Return on Capital Employed (%) 25.46 25.06 18.64 21.48 8.40 8.68 10.07 5.68 9.32
Return on Assets (%) 16.21 14.60 11.39 14.08 4.24 5.17 6.58 3.54 5.20

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 14,990 18,525 25,638 32,982 36,640 38,314 41,409 45,264 46,463 48,011
Non Curr. Liab. 199 1,748 2,335 2,170 600 46 77 246 -1,515 -1,364
Curr. Liab. 2,841 5,990 16,147 13,144 17,887 19,864 17,340 15,706 16,146 17,201
Minority Int. 1,635 1,921 2,851 4,085 3,791 3,884 3,314 3,860 3,017 3,055
Equity & Liab. 19,665 28,184 46,972 52,381 58,917 62,109 62,139 65,077 64,110 66,903
Non Curr. Assets 8,162 9,498 18,056 22,440 25,964 30,473 31,070 33,423 33,668 31,888
Curr. Assets 11,503 18,686 28,916 29,941 32,954 31,636 31,069 31,654 30,442 35,015
Misc. Exp. not W/O 0 0
Total Assets 19,665 28,184 46,972 52,381 58,917 62,109 62,139 65,077 64,110 66,903

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 16,080 27,392 28,109 31,308 26,416 29,066 32,838 33,498 38,654 39,698
Other Income 593 638 658 1,030 912 1,059 652 859 1,437 1,078
Total Income 16,673 28,030 28,767 32,338 27,328 30,125 33,489 34,357 40,092 40,775
Total Expenditure -9,121 -19,616 -19,950 -21,626 -20,881 -22,792 -25,863 -25,030 -28,773 -29,543
PBIDT 7,552 8,414 8,817 10,712 6,447 7,333 7,626 9,327 11,319 11,232
Interest -44 -579 -523 -400 -518 -555 -303 -141 -127 -106
Depreciation -409 -1,195 -1,038 -1,265 -1,500 -1,753 -2,053 -2,080 -2,144 -2,229
Taxation -702 -915 -914 -1,212 -911 -601 -823 -515 -1,076 -869
Exceptional Items -2,517 -238 -685 -951 -1,214 -261 -4,306 -4,567 -3,936
PAT 3,879 5,488 5,657 7,836 2,568 3,209 4,187 2,285 3,406 4,093
Minority Interest -738 -936 -1,113 -882 -447 -542 -407 631 -117 -189
Share Associate -13 1 10 -25 -1 -15 -12 -17 -14
Other Related Items
Consolidated Net Profit 3,141 4,539 4,546 6,964 2,096 2,665 3,765 2,904 3,273 3,889
Adjusted EPS 15 22 19 29 9 11 16 12 14 16

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 3,357 3,959 5,616 6,686 7,082 3,907 2,196 6,555 6,170 8,985
Cash Fr. Inv. -2,635 -2,367 -2,866 -4,372 -4,222 -3,371 -681 -2,589 536 -5,725
Cash Fr. Finan. -665 507 -1,187 -1,889 -2,285 -1,539 -2,731 -5,715 -5,980 -5,193
Net Change 57 2,099 1,563 426 575 -1,003 -1,215 -1,749 726 -1,934
Cash & Cash Eqvt 2,069 4,359 7,286 8,032 8,642 7,906 7,062 5,677 6,273 4,508

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 54.69 54.69 54.48 54.48 54.48 54.48 54.48 54.48 54.48
Public 45.31 45.31 45.52 45.52 45.52 45.52 45.52 45.52 45.52
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 10.35 9.09 9.01 8.62 6.36 6.52 4.79 5.57 4.04

Announcements View Details >>

Wed, 28 Sep 2022
General updates
Sun Pharmaceutical Industries Limited has informed the Exchange about Update on Acquisition of Uractiv Portfolio
Fri, 23 Sep 2022
Loss of share certificate
Sun Pharmaceutical Industries Limited has informed the Exchange about Loss of share certificate
Thu, 22 Sep 2022
Closure of trading window
Sun Pharmaceutical Industries Limited has informed the Exchange about Closure of trading window

Technical Scans View Details >>

Wed, 28 Sep 2022
Higher Trade Quantity Higher Trade Quantity
Closing Above Previous High Closing Above Previous High
Making Lower Lows for 3 days Making Lower Lows for 3 days
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase 3 Months High Increase 3 Months

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Divi's Laboratories Ltd. 98,114.53 3,708.95 +0.2%
Cipla Ltd. 88,495.80 1,110.50 +1.2%
Dr. Reddy's Laboratories Ltd. 71,034.40 4,375.00 +2.5%
Apollo Hospitals Enterprise Ltd. 61,344.29 4,382.80 +2.7%
Torrent Pharmaceuticals Ltd. 50,536.67 1,538.30 +2.9%
Alkem Laboratories Ltd. 39,477.37 3,194.20 -3.1%
Max Healthcare Institute Ltd. 39,199.20 397.15 -2.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Divi's Laboratories Ltd. Consolidated 2022-06 31.60 3,708.95 +0.2%
Cipla Ltd. Consolidated 2022-06 35.56 1,110.50 +1.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.75 4,375.00 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 69.44 4,382.80 +2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 63.09 1,538.30 +2.9%
Alkem Laboratories Ltd. Consolidated 2022-06 30.25 3,194.20 -3.1%
Max Healthcare Institute Ltd. Consolidated 2022-06 62.13 397.15 -2.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Divi's Laboratories Ltd. Consolidated 2022-06 7.89 3,708.95 +0.2%
Cipla Ltd. Consolidated 2022-06 4.12 1,110.50 +1.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.51 4,375.00 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.32 4,382.80 +2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 7.91 1,538.30 +2.9%
Alkem Laboratories Ltd. Consolidated 2022-06 4.50 3,194.20 -3.1%
Max Healthcare Institute Ltd. Consolidated 2022-06 6.09 397.15 -2.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,708.95 +0.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,110.50 +1.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,375.00 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,382.80 +2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,538.30 +2.9%
Alkem Laboratories Ltd. Consolidated 2022-03 0.30 3,194.20 -3.1%
Max Healthcare Institute Ltd. Consolidated 2022-03 0.12 397.15 -2.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,708.95 +0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,110.50 +1.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,375.00 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,382.80 +2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,538.30 +2.9%
Alkem Laboratories Ltd. Consolidated 2022-03 20.99 3,194.20 -3.1%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 397.15 -2.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,708.95 +0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,110.50 +1.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,375.00 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,382.80 +2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,538.30 +2.9%
Alkem Laboratories Ltd. Consolidated 2022-03 20.99 3,194.20 -3.1%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 397.15 -2.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,708.95 +0.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,110.50 +1.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,375.00 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,382.80 +2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,538.30 +2.9%
Alkem Laboratories Ltd. Consolidated 2022-03 10,634.19 3,194.20 -3.1%
Max Healthcare Institute Ltd. Consolidated 2022-03 3,931.46 397.15 -2.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,708.95 +0.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,110.50 +1.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,375.00 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,382.80 +2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,538.30 +2.9%
Alkem Laboratories Ltd. Consolidated 2022-03 1,680.32 3,194.20 -3.1%
Max Healthcare Institute Ltd. Consolidated 2022-03 605.05 397.15 -2.2%

FAQ's On Sun Pharmaceutical Industries Ltd.

What is Sun Pharma Inds. share price?

Can I buy Sun Pharma Inds. shares now?

What is the Dividend Yield of Sun Pharma Inds.?

What is the Market Cap of Sun Pharma Inds.?

What are the key metrics to analyse Sun Pharma Inds.?

What is the 52 Week High and Low of Sun Pharma Inds.?

What is the trend of Sun Pharma Inds. share price?